On Nov 12, 2025, XBIT reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
What were XBiotech Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, XBiotech Inc reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to XBiotech Inc's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is XBiotech Inc expected to report next?
The next earning report is scheduled for Mar 16, 2026.
What are the forecasts for XBiotech Inc's next earnings report?
Based on --
analysts, XBiotech Inc is expected to report EPS of -- and revenue of -- for Q4 2025.